FORA
Forian Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$2.17
+0.00%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 30.1M | 30.3M | 20.2M | 20.5M | 16.4M |
| Cost of Revenue | 16.0M | 14.4M | 7.3M | 5.5M | 5.0M |
| Gross Profit | 14.1M | 15.9M | 12.8M | 15.0M | 11.4M |
| Operating Expenses | |||||
| R&D Expense | 3.3M | 2.9M | 1.4M | 1.4M | 4.0M |
| SG&A Expense | 14.7M | 15.4M | 16.9M | 18.5M | 20.8M |
| General & Admin Expense | 8.6M | 9.4M | 12.5M | 13.6M | 16.9M |
| Selling & Marketing Expense | 6.1M | 6.0M | 4.3M | 4.9M | 3.9M |
| Other Expenses | 110.6K | — | 1.5M | 674.3K | 5.5M |
| Total Operating Expenses | 18.1M | 18.4M | 19.8M | 20.6M | 30.3M |
| Cost and Expenses | 34.1M | 32.7M | 27.1M | 26.1M | 35.4M |
| Operating Income (EBIT) | (4.0M) | (2.5M) | (7.0M) | (5.6M) | (19.0M) |
| Non-Operating | |||||
| Interest Income | 1.1M | 1.3M | 2.4M | 2.3M | 266.2K |
| Interest Expense | 89.7K | 142.4K | 708.9K | 834.8K | 846.1K |
| Net Interest Income | 997.6K | 1.1M | 1.7M | 1.5M | (579.9K) |
| Other Non-Op Income/Expense | (843.7K) | (177.4K) | 3.3M | 7.4M | (215.2K) |
| Non-Operating Income (excl Interest) | 357.7K | — | (4.0M) | (8.2M) | (630.9K) |
| EBT (Pre-Tax Income) | (4.9M) | (2.6M) | (3.7M) | 1.8M | (19.2M) |
| Income Tax Expense | 250.5K | 228.0K | 66.6K | 85.7K | 24.0K |
| Bottom Line | |||||
| Net Income | (5.1M) | (2.9M) | (3.8M) | 11.1M | (26.0M) |
| Earnings from Cont. Ops | (5.1M) | (2.9M) | (3.8M) | 1.7M | (19.2M) |
| Earnings from Discont. Ops | — | — | — | 9.4M | (6.8M) |
| Bottom Line Net Income | (5.1M) | (2.9M) | (3.8M) | 11.1M | (26.0M) |
| Per Share | |||||
| Basic EPS | ($0.17) | ($0.09) | ($0.12) | $0.36 | ($0.81) |
| Diluted EPS | ($0.17) | ($0.09) | ($0.12) | $0.36 | ($0.81) |
| Revenue Per Share | $0.96 | $0.97 | $0.65 | $0.64 | $0.51 |
| Shares | |||||
| Basic Shares Outstanding | 31.2M | 31.1M | 31.1M | 32.0M | 32.0M |
| Diluted Shares Outstanding | 31.2M | 31.1M | 31.1M | 32.2M | 32.0M |
| Profitability Metrics | |||||
| EBITDA | (4.1M) | (2.2M) | (2.9M) | 2.8M | (18.3M) |
| D&A | 232.2K | 231.1K | 85.4K | 96.3K | 67.2K |
| EBIT | (4.4M) | (2.5M) | (3.0M) | 2.7M | (18.3M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026